BCSFVSDNA• 6 Months (Normalized)
BCSF vs DNA (Bain Capital Specialty Finance Inc. vs Ginkgo Bioworks Holdings Inc.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BCSF Performance $10.9
-13.56%
Bain Capital Specialty Finance Inc.
Normalized Baseline0.00%
DNA Performance $14.98
+117.73%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
-131.29 pts
DNA outperforming by 131.29 percentage points
BCSFDNA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BCSF DNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | BCSF Price | BCSF Gain (%) | DNA Price | DNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $10.90 | -13.56% | $14.98 | +117.73% | -131.29% |
| Oct 02, 2026 | $11.05 | -12.37% | $12.35 | +79.51% | -91.88% |
| Oct 01, 2026 | $- | $12.50 | +81.69% | - | |
| Sep 30, 2026 | $- | $12.83 | +86.48% | - | |
| Sep 29, 2026 | $- | $11.96 | +73.84% | - | |
| Sep 28, 2026 | $- | $10.46 | +52.03% | - | |
| Sep 25, 2026 | $11.08 | -12.13% | $10.66 | +54.94% | -67.07% |
| Sep 24, 2026 | $11.12 | -11.82% | $10.25 | +48.98% | -60.80% |
| Sep 23, 2026 | $11.07 | -12.21% | $8.58 | +24.71% | -36.92% |
| Sep 22, 2026 | $11.22 | -11.02% | $9.37 | +36.19% | -47.21% |
| Sep 21, 2026 | $11.21 | -11.10% | $7.98 | +15.99% | -27.09% |
| Sep 18, 2026 | $11.09 | -12.05% | $7.88 | +14.53% | -26.58% |
| Sep 17, 2026 | $11.30 | -10.39% | $7.84 | +13.95% | -24.34% |
| Sep 16, 2026 | $11.08 | -12.13% | $7.06 | +2.62% | -14.75% |
| Sep 15, 2026 | $11.07 | -12.21% | $6.99 | +1.60% | -13.81% |
Page 1 of 9